Skip to main content

Table 2 Antibodies and immunohistological staining procedures

From: Adenomyoepithelial tumours and myoepithelial carcinomas of the breast – a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells

Antigen

Antibody

Source

Dilution

Detection

Pretreatment

Vimentin

mAb V9

DAKO, Glostrup, Denmark

1:1000

LSAB/ HRP

Steamer

Ki-67 nuclear antigen

mAb MIB-1

DAKO, Glostrup, Denmark

1:100

LSAB/AP

Steamer

broad spectrum Cks

mAb KL-1

Immunotech, Marseille, France

1:50

LSAB/ HRP

Steamer

Ck5/6

mAb D5/16B4

Zymed, San Francisco, USA

1:50

LSAB/ AP

Steamer

Ck14

mAb Ll002

dianova GmbH, Hamburg, Germany

1:50

LSAB/ AP

Steamer

Ck8/18

mAb 5D3

dianova GmbH, Hamburg, Germany

1:40

LSAB/ AP

Steamer

Ck19

mAb RCK108

DAKO, Glostrup, Denmark

1:80

LSAB/ AP

Steamer

P63

mAb 4A4

DAKO, Glostrup, Denmark

1:100

LSAB/ AP

Steamer

Sm-α-actin (SMA)

mAb 1A4

DAKO, Glostrup, Denmark

1:3000

LSAB/ AP

Steamer

S-100 protein

Rabbit, polyclonal

DAKO, Glostrup, Denmark

1:1000

LSAB/ HRP

-

Estrogen receptor

mAb 6F11

Novocastra, Newcastle upon Tyne, UK

1:200

LSAB/ AP

Steamer

Progesterone receptor

mAb 16

Novocastra, Newcastle upon Tyne, UK

1:1000

LSAB/ AP

Steamer

c-Kit

Rabbit, polyclonal

DAKO, Glostrup, Denmark

1:100

LSAB/ AP

Steamer

  1. mAb, mouse monoclonal antibody